180 related articles for article (PubMed ID: 33603121)
21. Isolation and Antibiogram of Clostridium tetani from Clinically Diagnosed Tetanus Patients.
Hanif H; Anjum A; Ali N; Jamal A; Imran M; Ahmad B; Ali MI
Am J Trop Med Hyg; 2015 Oct; 93(4):752-6. PubMed ID: 26175031
[TBL] [Abstract][Full Text] [Related]
22. The structural gene for tetanus neurotoxin is on a plasmid.
Finn CW; Silver RP; Habig WH; Hardegree MC; Zon G; Garon CF
Science; 1984 May; 224(4651):881-4. PubMed ID: 6326263
[TBL] [Abstract][Full Text] [Related]
23. Comparative genomic analysis of a neurotoxigenic Clostridium species using partial genome sequence: Phylogenetic analysis of a few conserved proteins involved in cellular processes and metabolism.
Alam SI; Dixit A; Tomar A; Singh L
Anaerobe; 2010 Apr; 16(2):147-54. PubMed ID: 19527791
[TBL] [Abstract][Full Text] [Related]
24. Regulation of toxin and bacteriocin synthesis in Clostridium species by a new subgroup of RNA polymerase sigma-factors.
Dupuy B; Matamouros S
Res Microbiol; 2006 Apr; 157(3):201-5. PubMed ID: 16439101
[TBL] [Abstract][Full Text] [Related]
25. Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani.
Hara T; Matsuda M; Yoneda M
Biken J; 1977 Dec; 20(3-4):105-15. PubMed ID: 352338
[TBL] [Abstract][Full Text] [Related]
26. Tetanus in animals.
Popoff MR
J Vet Diagn Invest; 2020 Mar; 32(2):184-191. PubMed ID: 32070229
[TBL] [Abstract][Full Text] [Related]
27. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
28. Reversible suppression of glutamatergic neurotransmission of cerebellar granule cells in vivo by genetically manipulated expression of tetanus neurotoxin light chain.
Yamamoto M; Wada N; Kitabatake Y; Watanabe D; Anzai M; Yokoyama M; Teranishi Y; Nakanishi S
J Neurosci; 2003 Jul; 23(17):6759-67. PubMed ID: 12890769
[TBL] [Abstract][Full Text] [Related]
29. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
30. Genomic insights into the evolution and ecology of botulinum neurotoxins.
Mansfield MJ; Doxey AC
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29684130
[TBL] [Abstract][Full Text] [Related]
31. Inducible lysis clostridium tetani.
Prescott LM; Altenbern RA
J Bacteriol; 1967 Apr; 93(4):1220-6. PubMed ID: 4226682
[TBL] [Abstract][Full Text] [Related]
32. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.
Akbulut D; Grant KA; McLauchlin J
J Clin Microbiol; 2005 Sep; 43(9):4342-8. PubMed ID: 16145075
[TBL] [Abstract][Full Text] [Related]
33. Expression of tetanus toxin subfragments in vitro and characterization of epitopes.
Andersen-Beckh B; Binz T; Kurazono H; Mayer T; Eisel U; Niemann H
Infect Immun; 1989 Nov; 57(11):3498-505. PubMed ID: 2478475
[TBL] [Abstract][Full Text] [Related]
34. Clostridium tetani growth and toxin production in the intestines of germfree rats.
Wells CL; Balish E
Infect Immun; 1983 Aug; 41(2):826-8. PubMed ID: 6347898
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a targeted LC-MS/MS quantitation method to monitor cell culture expression of tetanus neurotoxin during vaccine production.
Francotte A; Esson R; Abachin E; Vanhamme M; Dobly A; Carpick B; Uhlrich S; Dierick JF; Vanhee C
Talanta; 2022 Jan; 236():122883. PubMed ID: 34635263
[TBL] [Abstract][Full Text] [Related]
36. Autism and Clostridium tetani.
Bolte ER
Med Hypotheses; 1998 Aug; 51(2):133-44. PubMed ID: 9881820
[TBL] [Abstract][Full Text] [Related]
37. Tetanus toxin production is triggered by the transition from amino acid consumption to peptides.
Licona-Cassani C; Steen JA; Zaragoza NE; Moonen G; Moutafis G; Hodson MP; Power J; Nielsen LK; Marcellin E
Anaerobe; 2016 Oct; 41():113-124. PubMed ID: 27492724
[TBL] [Abstract][Full Text] [Related]
38. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
Minamitani T; Kiyose K; Otsubo R; Ito T; Akiba H; Furuta RA; Inoue T; Tsumoto K; Satake M; Yasui T
Sci Rep; 2021 Jun; 11(1):12134. PubMed ID: 34108521
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the tetanus toxin from two different strains of Clostridium tetani.
LARGIER JF
J Immunol; 1956 Jun; 76(6):393-8. PubMed ID: 13332240
[No Abstract] [Full Text] [Related]
40. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
